Current methods for absorbed dose planning for radioiodine treatment of hyperthyroidism in Sweden

Physica Medica

Volumn 20, Issue 3, 2004, Pages 99-103

  Jönsson, Helene ^a,b   Mattsson, Sören ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Swedish Radiation Protection Authority   (Sweden)

Author keywords

Absorbed dose; Hyperthyroidism; Radioiodine; Therapy

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ARTICLE; DOSE CALCULATION; DRUG HALF LIFE; DRUG UPTAKE; HUMAN; HYPERTHYROIDISM; RADIATION ABSORPTION; RADIATION DOSE; SWEDEN; THYROID GLAND; TREATMENT OUTCOME;

EID: 13444265964     PISSN: 11201797     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jönsson H, Mattsson S. Single uptake measurement for absorbed dose planning for radioiodine treatment of hyperthyroidism. Cancer Biother Radiopharm 2003: 18; 473-479.
2. Bockisch A, Jamitzky T, Derwanz R, Biersack H. J. Optimized dose planning of radioiodine therapy of benign thyroidal diseases. J Nucl Med 1993: 34; 1632-1638.
3. 131I. Wis Med J 1995: 94; 21-25.
4. de Bruin T, Croon C, de Klerk J, van Isselt J. Standardized radioiodine therapy in Graves' disease: the persistent effect of thyroid weight and radioiodine uptake on outcome. J Intern Med 1994: 236; 507-513.
5. Bajnok L, Mezosi E, Nagy E, Szabo J, Sztojka I, Varga J, Galuska L, Leovey A. Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary? Thyroid 1999: 9; 865-869.
6. Berg G, Michanek A, Holmberg E, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 1996: 37; 228-232.
7. EANM (European Association of Nuclear M edicine). EANM procedure guidelines for therapy with iodine-131. Eur J Nucl Med 2003: 30; BP27-BP31.
8. 131I. J Nucl Med 2002: 43; 856-861.
9. Dietlein M, Dressier J, Eschner W, Lassmann M, Leisner B, Reiners C, Schicha H. Procedure guideline for radioiodine test (version 2). Nuklearmedizin 2003: 42; 116-119.
10. 124I. Eur J Nucl Med 1985: 10 (9-10); 472-476.
11. Hermans R, Bouillon R, Laga K, Delaere P R, De Foer B, Marchal G, Baert A.L., Estimation of thyroid gland volume by spiral computed tomography. Eur Radiol 1997: 7; 214-216.
12. Reinartz P, Sabri O, Zimny M, Nowak B, Cremerius U, Setani K, Bull U. Thyroid volume measurement in patients prior to radioiodine therapy: comparison between three-dimensional magnetic resonance imaging and ultrasonography. Thyroid 2002: 12 (8); 713-717.
13. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Reduction in thyroid volume after radioiodine therapy of Graves' hyperthyroidism: result of a prospective, randomized, multicentre study. Eur J Clin Invest 1996: 26 (1); 59-63.
14. Traino A, Di Martino F, Lazzeri M, Stabin M. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 2000: 45; 121-129.
15. Di Martino F, Traino A, Brill A, Stabin M, Lazzeri M. A theoretical model for prescription of the patient specific therapeutic activity for radioiodine therapy of Graves' disease. Phys Med Biol 2002: 47; 1493-1499.
16. Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: What have we learned after 50 years. J Nucl Med. 1993: 34; 1638-1641.
17. Haase A, Bahre M, Lauer I, Meller B, Richter E. Radioiodine therapy in Graves' hyperthyroidism: determination of individual-optimum target dose. Exp Clin Endocrinol Diabetes. 2000: 108; 133-137.
18. Jönsson H, Mattsson S. Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism. Radiat Prot Dosim (in press).
19. Jarlov A, Hegedus L, Kristensen L, Nygaard B, Hansen J. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clin End 1995: 45; 325-329.
20. Ratcliffe G, Fogelman I, Maisey M. The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime. Br J Rad 1986: 59; 1105-1107.
21. The Swedish Radiation Protection Authority. The Swedish Radiation Protection Institute's Regulations and General Advice on Nuclear Medicine. 2000; SSI FS 2000: 3.
22. European Communities: Council directive 97/43/Euratom of 30 June 1997 on health protection of individuals against the dangers of ionising radiation in relation to medical exposure. Official Journal of the European Communities L180, 9 July 1997.
23. ICRP (International Commission on Radiological Protection). 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Oxford Pergamon Press 1991 (Annals of the ICRP 21: no 1-3).
24. Thomas S R. Options for radionuclide therapy: from fixed activity to patient-specific treatment planning. Cancer Biother Radiopharm 2002: 17 (1); 71-82.